Veralto Corporation · VLTO · FY2026 Q2 · Calendar Q3 2026

Veralto raises EPS outlook as industrial water demand strengthens

The supplied analysis supports a constructive but conditional view: resilient industrial water and PQI demand, acquisitions, and workflow innovation are supporting growth, while execution, municipal budgets, input costs, and uncertain tariff refunds remain important constraints.

Reported After market closeNYSEIndustrials $23.35B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $1.11 Consensus $1.01
EPS surprise +9.9% Reported versus consensus
Reported revenue $1.47B Consensus $1.45B
Revenue surprise +1.3% Reported versus consensus

Market reaction

event-close to next-session close
Stock move +0.4% Event window
SPY move -1.5% Same window
Abnormal move +1.9% Stock minus SPY
Volume 1.7× Versus trailing sessions
Subsequent drift -0.1% Up to 20 sessions
VLTOSPY benchmark

Ask FN2 about VLTO FY2026 Q2

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Q2 performance was stronger than the prior-quarter backdrop, with 7.6% sales growth, 19.4% adjusted EPS growth, robust free cash flow, and a higher full-year EPS outlook. Management also highlighted Alfaa UV and AI-enabled PQI workflows as incremental priorities.

Guidance delta

Full-year adjusted EPS guidance was raised to $4.35–$4.43 from $4.20–$4.28 in the prior quarter.

Key takeaways

  • Q2 sales grew 7.6% year over year and adjusted EPS rose 19.4%.
  • Management expects second-half core sales growth of 5–6%.
  • Industrial water demand from data centers, power, mining, and semiconductors is a key growth driver.
  • Alfaa UV expands the water-treatment portfolio, while GlobalVision adds AI-enabled workflow capabilities.
  • Management expects 25–50 basis points of margin expansion from pricing and cost-out actions.

Management priorities

  • Integrate and scale Alfaa UV within Trojan UV.
  • Launch PQI products and AI-enhanced digital workflow solutions.
  • Pursue aligned bolt-on acquisitions and opportunistic share repurchases.
  • Advance cost optimization and pricing actions to support margin expansion.

Follow VLTO with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
VLTO EPS earnings history estimate and actual scatter chart 9 reported fiscal quarters and 4 future estimate-only quarters. Q1 '24 estimate $0.76 Q1 '24 actual $0.84, beat Q2 '24 estimate $0.80 Q2 '24 actual $0.85, beat Q3 '24 estimate $0.85 Q3 '24 actual $0.89, beat Q2 '25 estimate $0.88 Q2 '25 actual $0.93, beat Q3 '25 estimate $0.95 Q3 '25 actual $0.99, beat Q4 '25 estimate $0.98 Q4 '25 actual $1.04, beat Q1 '26 estimate $1.00 Q1 '26 actual $1.07, beat Q2 '26 estimate $1.01 Q2 '26 actual $1.11, beat Q3 '26 estimate $1.09 Q4 '26 estimate $1.13 Q1 '27 estimate $1.15 Q2 '27 estimate $1.14
Show 1 more >

Analyst Consensus ?

ConsensusHold13 ratings
Bullish646.2%
Neutral753.8%
Bearish00.0%

Analyst 52W Price Targets

$95.88Current
$102Low
$108.75Average
$119High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 23, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
UBS Neutral NeutralMaintainJul 30, 2026
Stifel Buy BuyMaintainJul 30, 2026
RBC Capital Sector Perform Sector PerformMaintainJul 30, 2026
Citigroup Neutral NeutralMaintainJul 30, 2026
BNP Paribas Outperform OutperformMaintainJul 30, 2026
Barclays Overweight OverweightMaintainJul 30, 2026
Jefferies Hold BuyDowngradeDec 10, 2025
BMO Capital Outperform OutperformMaintainNov 25, 2025
Baird Neutral NeutralMaintainJul 30, 2025
TD Cowen Hold HoldMaintainJul 30, 2024
Goldman Sachs Buy BuyMaintainJul 29, 2024
Deutsche Bank Hold HoldMaintainJul 29, 2024
Vertical Research Buy HoldUpgradeOct 16, 2023
Show less

Named analyst price targets

Upside is calculated against the persisted current price $95.88. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
UBSAnalyst unavailable$104$94.18 +8.5%Jul 30, 2026
Robert W. BairdAnalyst unavailable$111$95.21 +15.8%Jul 30, 2026
RBC CapitalAnalyst unavailable$109$94.8 +13.7%Jul 30, 2026
Stifel NicolausAnalyst unavailable$114$98.83 +18.9%Jul 30, 2026
Stifel NicolausAnalyst unavailable$111$93.81 +15.8%Jul 20, 2026
Wolfe ResearchAnalyst unavailable$109$92.12 +13.7%Jul 9, 2026
Robert W. BairdMichael Halloran$103$89.47 +7.4%Apr 30, 2026
BarclaysAnalyst unavailable$113$89.47 +17.9%Apr 30, 2026
Stifel NicolausNathan Jones$110$90.85 +14.7%Apr 14, 2026
BMO CapitalAnalyst unavailable$108$92.81 +12.6%Feb 11, 2026
UBSJoshua Spector$102$91.7 +6.4%Feb 6, 2026
Stifel NicolausNathan Jones$118$90.35 +23.1%Feb 5, 2026
RBC CapitalDeane Dray$102$89 +6.4%Feb 5, 2026
Robert W. BairdMichael Halloran$108$91.41 +12.6%Feb 5, 2026
BarclaysWilliam Grippin$117$91.41 +22.0%Feb 5, 2026
JefferiesAnalyst unavailable$105$98.34 +9.5%Dec 10, 2025
BMO CapitalAnalyst unavailable$114$103.64 +18.9%Nov 25, 2025
RBC CapitalAnalyst unavailable$111$100.26 +15.8%Oct 30, 2025
BarclaysAnalyst unavailable$121$99.5 +26.2%Oct 30, 2025
BarclaysWilliam Grippin$119$107.14 +24.1%Oct 6, 2025
BarclaysAnalyst unavailable$120$107.06 +25.2%Sep 18, 2025
Stifel NicolausAnalyst unavailable$120$105.78 +25.2%Jul 30, 2025
BMO CapitalJohn McNulty$119$110.46 +24.1%Sep 30, 2024
BMO CapitalJohn McNulty$117$106.28 +22.0%Jul 29, 2024
Stifel NicolausNathan Jones$117$104.87 +22.0%Jul 29, 2024
Robert W. BairdMichael Halloran$112$106.23 +16.8%Jul 29, 2024
RBC CapitalDeane Dray$108$106.25 +12.6%Jul 29, 2024
Argus ResearchJohn Eade$110$97.27 +14.7%May 7, 2024
BMO CapitalJohn McNulty$101$92.4 +5.3%Apr 25, 2024
RBC CapitalDeane Dray$101$92.4 +5.3%Apr 25, 2024
Goldman SachsBrian Lee$104$89.46 +8.5%Mar 22, 2024
RBC CapitalDeane Dray$78$70.74 -18.6%Nov 3, 2023
Show less

Track every rating change on VLTO the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Veralto Corporation is a global provider specializing in critical solutions across water quality management, brand protection, and packaging aesthetics. Its operations are structured into two primary divisions: Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment delivers advanced instrumentation and treatment technologies designed for the precise measurement, analysis, and purification of water. These solutions cater to a broad spectrum of applications, from residential and commercial settings to municipal systems, industrial processes, research facilities, and natural environments. Esteemed brands like Hach, Trojan Technologies, and ChemTreat fall under this segment, which also supplies essential chemical reagents, support services, and digital tools for comprehensive water management. The PQI segment focuses on enhancing product integrity and brand appeal.…

Historical context

All VLTO earnings

Industrials peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the VLTO recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-07-29T17:07:40.500555+00:00
  2. FN2 earnings calendar · 2026-09-02T01:23:14.593608+00:00
  3. Polygon adjusted daily market bars · 2026-09-23T20:30:54.603326+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-23T20:30:54.600302+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-09-23. For educational purposes only; not investment advice.